The Japanese Journal of Pharmacology
Full Papers
Menatetrenone Prevents Osteoblast Dysfunction in Unilateral Sciatic Neurectomized Rats
Yoshiko IwasakiHideyuki YamatoHisashi MurayamaTakeshi TakahashiIkuko EzawaKiyoshi KurokawaMasafumi Fukagawa
Author information
JOURNALS FREE ACCESS

Volume 90 (2002) Issue 1 Pages 88-93

Details
Download PDF (113K) Contact us
Abstract

Menatetrenone (MK-4) inhibits bone resorption and enhances osteoblast-induced mineralization. In this study, we examined whether MK-4 administration had beneficial effects on osteoblast dysfunction and trabecular microstructure as well as on bone volume loss in a rat model of osteopenia. Male Sprague-Dawley rats were neurectomized and administered MK-4 as a daily supplement. On Day 21 after neurectomy, significant bone loss was observed in the positive control rats. MK-4 prevented the decrease in bone mineral density of the distal metaphysis of the femur. The osteoclast surface per bone surface (Oc.S/BS) and the number of osteoclasts per bone perimeter (N.Oc/B.Pm) were reduced and the mineral apposition rate (MAR) decreased in the immobilized rats on Day 42, suggesting suppression of bone turnover. In contrast, administration with a low dose of menatetrenone led to an increase of MAR and bone formation rate (BFR), while Oc.S/BS and N.Oc/B.Pm remained at normal levels. These data suggested that MK-4 reduced the loss of trabecular bone, prevented osteoblast dysfunction to a certain extent, and contributed to preservation of the trabecular microstructure in this rat model of osteopenia induced by sciatic neurectomy.

Information related to the author
© The Japanese Pharmacological Society 2002
Previous article Next article

Recently visited articles
feedback
Top